Several studies have demonstrated that TNF receptors (TNFR) deficiency, administration of anti-TNF or selective anti-TNFR1 antibody can ameliorate NAFLD in murine models [[33], [34], [35]]. The gene discussed is TNFRSF1A; the disease is metabolic dysfunction-associated steatotic liver disease.